HC Wainwright & Co. Maintains Buy on Gossamer Bio, Lowers Price Target to $2

Benzinga Newsdesk www.benzinga.com Negative 48.1%

Neg 48.1% Neu 0% Pos 0%

HC Wainwright & Co. analyst Patrick R. Trucchio maintains Gossamer Bio (NASDAQ:GOSS) with a Buy and lowers the price target from $5 to $2.